icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Pharmstandard posts 1H 2010 Net Profit of 2.8 billion roubles

Pharmstandard posts 1H 2010 Net Profit of 2.8 billion roubles
Leading Russian drug maker Pharmstandard has posted a 1H 2010 net profit of 2.8 billion roubles under IFRS.

The bottom line was up 7% year on year, despite EBITDA slightly going down to 3.87 billion roubles from 3.95 billion roubles a year earlier, but revenues also rose 15% year on year to 11.5 billion roubles.

The pharmaceutical company said in the accompanying statement that mostly drugs of its own production contributed to a 15.4% growth of sales of pharmaceutical products, which in turn were up 13.6%.

Pharmstandard also indicated that Arbidol remained the leader in pharmaceutical retail sales across Russia, with sales of the drug growing 29% during the first six months of 2010.